{
 "PrintNo":"A1462","Session":2025,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2025-01-09T13:15:01.091886Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2025-01-09","Committee":"Insurance"}],
 "Actions":[{"Text":"REFERRED TO INSURANCE","Date":"2025-01-09","Chamber":"ASSEMBLY"}],
 "Sponsors":[
  {"ID":1105,"Name":"Pamela J. Hunter","Short":"HUNTER"},{"ID":540,"Name":"Amy Paulin","Short":"PAULIN"},
  {"ID":484,"Name":"David Weprin","Short":"WEPRIN"},{"ID":675,"Name":"Phil Steck","Short":"STECK"}
 ],
 "Title":"Establishes a mandated window of five business days for both Medicaid and private insurers to respond to pre-authorization claims for testing and/or treatments made by physicians on behalf of oncology patients",
 "Summary":"Establishes a mandated window of five business days for both Medicaid and private insurers to respond to pre-authorization claims for testing and/or treatments made by physicians on behalf of oncology patients.",
 "LawSection":"Insurance Law","LawCode":"Amd ยง3238, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to establishing a mandated window of five business days for both Medicaid and private insurers to respond to pre-authorization claims for testing and/or treatments made by physicians on behalf of oncology patients",
 "SameAsPrintNo":"S586-2025","PreviousVersions":["A10679-2023"]
}